BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 26642773)

  • 1. Atrial Fibrillation During or After TAVI: Incidence, Implications and Therapeutical Considerations.
    Vavuranakis M; Kolokathis AM; Vrachatis DA; Kalogeras K; Magkoutis NA; Fradi S; Ghostine S; Karamanou M; Tousoulis D
    Curr Pharm Des; 2016; 22(13):1896-903. PubMed ID: 26642773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Atrial Fibrillation and Atrial Flutter by Pacemaker Device Interrogation After Transcatheter Aortic Valve Replacement (TAVR): Implications for Management.
    Megaly M; Garcia S; Anzia LE; Morley P; Garberich R; Gornick CC; Lesser J; Sorajja P; Gössl M; Sengupta J
    J Invasive Cardiol; 2019 Jul; 31(7):E177-E183. PubMed ID: 31257211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, Predictors, Management, and Clinical Significance of New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Implantation.
    Yoon YH; Ahn JM; Kang DY; Ko E; Lee PH; Lee SW; Kim HJ; Kim JB; Choo SJ; Park DW; Park SJ
    Am J Cardiol; 2019 Apr; 123(7):1127-1133. PubMed ID: 30683423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of and Prognostic Significance of Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Implantation.
    Sannino A; Stoler RC; Lima B; Szerlip M; Henry AC; Vallabhan R; Kowal RC; Brown DL; Mack MJ; Grayburn PA
    Am J Cardiol; 2016 Nov; 118(10):1527-1532. PubMed ID: 27666171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal changes of new-onset atrial fibrillation in patients randomized to surgical or transcatheter aortic valve replacement.
    Jørgensen TH; Thyregod HG; Tarp JB; Svendsen JH; Søndergaard L
    Int J Cardiol; 2017 May; 234():16-21. PubMed ID: 28258844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of new onset atrial fibrillation after transcatheter aortic valve implantation: A FRANCE 2 registry substudy.
    Furuta A; Lellouche N; Mouillet G; Dhanjal T; Gilard M; Laskar M; Eltchaninoff H; Fajadet J; Iung B; Donzeau-Gouge P; Leprince P; Leuguerrier A; Prat A; Dubois-Rande JL; Teiger E
    Int J Cardiol; 2016 May; 210():72-9. PubMed ID: 26930641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of new-onset versus pre-existing atrial fibrillation on outcomes after transcatheter aortic valve replacement/implantation.
    Nso N; Emmanuel K; Nassar M; Bhangal R; Enoru S; Iluyomade A; Marmur JD; Ilonze OJ; Thambidorai S; Ayinde H
    Int J Cardiol Heart Vasc; 2022 Feb; 38():100910. PubMed ID: 35146118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Onset Atrial Fibrillation Following Transcatheter and Surgical Aortic Valve Replacement: A Systematic Review and Meta-Analysis.
    Indja B; Woldendorp K; Vallely MP; Grieve SM
    Heart Lung Circ; 2020 Oct; 29(10):1542-1553. PubMed ID: 32327310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial fibrillation, stroke, and mortality rates after transcatheter aortic valve implantation.
    Yankelson L; Steinvil A; Gershovitz L; Leshem-Rubinow E; Furer A; Viskin S; Keren G; Banai S; Finkelstein A
    Am J Cardiol; 2014 Dec; 114(12):1861-6. PubMed ID: 25438914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Impact of Atrial Fibrillation in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: An Analysis From the SOURCE XT Prospective Multicenter Registry.
    Tarantini G; Mojoli M; Windecker S; Wendler O; Lefèvre T; Saia F; Walther T; Rubino P; Bartorelli AL; Napodano M; D'Onofrio A; Gerosa G; Iliceto S; Vahanian A
    JACC Cardiovasc Interv; 2016 May; 9(9):937-46. PubMed ID: 27085579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New-onset atrial fibrillation after surgical aortic valve replacement and transcatheter aortic valve implantation: a concise review.
    Jørgensen TH; Thygesen JB; Thyregod HG; Svendsen JH; Søndergaard L
    J Invasive Cardiol; 2015 Jan; 27(1):41-7. PubMed ID: 25589700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis of the impact of pre-existing and new-onset atrial fibrillation on clinical outcomes in patients undergoing transcatheter aortic valve implantation.
    Sannino A; Gargiulo G; Schiattarella GG; Perrino C; Stabile E; Losi MA; Galderisi M; Izzo R; de Simone G; Trimarco B; Esposito G
    EuroIntervention; 2016 Oct; 12(8):e1047-e1056. PubMed ID: 26610809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation.
    Amat-Santos IJ; Rodés-Cabau J; Urena M; DeLarochellière R; Doyle D; Bagur R; Villeneuve J; Côté M; Nombela-Franco L; Philippon F; Pibarot P; Dumont E
    J Am Coll Cardiol; 2012 Jan; 59(2):178-88. PubMed ID: 22177537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR).
    Herold J; Herold-Vlanti V; Sherif M; Luani B; Breyer C; Bonaventura K; Braun-Dullaeus R
    BMC Cardiovasc Disord; 2017 Dec; 17(1):298. PubMed ID: 29262768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New-onset atrial fibrillation detected by ambulatory ECG monitoring after transcatheter aortic valve implantation.
    Nuche J; Soliman F; Chavarría J; Okoh AK; Alvarado Mora H; Nault I; Natarajan MK; Russo M; Philippon F; Rodés-Cabau J
    EuroIntervention; 2024 May; 20(9):591-601. PubMed ID: 38726722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Atrial Fibrillation on Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI): The K-TAVI Registry.
    Lee SY; Choi KH; Park TK; Kim J; Kim EK; Park SJ; Park SW; Gwon HC; Chang K; Yu CW; Kim J; Choi YJ; Chae IH; Lee JH; Kim JH; Park JS; Kim WJ; Yoon YW; Ahn TH; Lee SR; Choi BJ; Yang TH; Choi CU; Hur SH; Oh SJ; Lee HC; Park H; Kim HS; Choi SH
    Yonsei Med J; 2023 Jul; 64(7):413-422. PubMed ID: 37365735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of atrial fibrillation on outcomes in patients who underwent transcatheter aortic valve replacement.
    Maan A; Heist EK; Passeri J; Inglessis I; Baker J; Ptaszek L; Vlahakes G; Ruskin JN; Palacios I; Sundt T; Mansour M
    Am J Cardiol; 2015 Jan; 115(2):220-6. PubMed ID: 25465936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of Susceptibility to Mortality and Heart Failure in Patients With Preexisting Atrial Fibrillation After Transcatheter Aortic Valve Implantation.
    Hioki H; Watanabe Y; Kozuma K; Nara Y; Kawashima H; Nagura F; Nakashima M; Kataoka A; Yamamoto M; Naganuma T; Araki M; Tada N; Shirai S; Yamanaka F; Hayashida K;
    Am J Cardiol; 2017 Nov; 120(9):1618-1625. PubMed ID: 28842144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and clinical impact of tachyarrhythmic events following transcatheter aortic valve replacement: A review.
    Nuche J; Panagides V; Nault I; Mesnier J; Paradis JM; de Larochellière R; Kalavrouziotis D; Dumont E; Mohammadi S; Philippon F; Rodés-Cabau J
    Heart Rhythm; 2022 Nov; 19(11):1890-1898. PubMed ID: 35952981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.
    Ryan T; Grindal A; Jinah R; Um KJ; Vadakken ME; Pandey A; Jaffer IH; Healey JS; Belley-Coté ÉP; McIntyre WF
    JACC Cardiovasc Interv; 2022 Mar; 15(6):603-613. PubMed ID: 35331452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.